Dalriada Therapeutics Won the FACIT Prospect Fund Award

February 6, 2018

Dalriada Therapeutics, Professor Gunning’s start-up company, won the Fight Against Cancer Innovation Trust (FACIT) Prospect Fund Award.

 

 

 

Please reload

Featured Posts

Gunning Group at TEDxMississauga

December 15, 2015

1/2
Please reload

Recent Posts
Please reload

Archive